Vitaspring Biomedical VSBC Cash Flow Statement (2017-2026)

OTC VSBC
$0.01 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT
Reported Financials

Vitaspring Biomedical Quarterly Cash Flow Statement

Periods 38 quarters
Latest Jul 2026

Vitaspring Biomedical reported cash from operations of $0.01M and free cash flow of $0.01M for the quarter ended Jul 2026, up 538.4% year over year. This cash flow statement covers 38 quarters of results from Apr 2017 through Jul 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Apr2017 Jul2017 Oct2017 Jan2018 Apr2018 Jul2018 Oct2018 Jan2019 Apr2019 Jul2019 Oct2019 Jan2020 Apr2020 Jul2020 Oct2020 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026 Jul2026
Operating Activities
Net Income
-0.14M1.23M0.28M-0.14M-0.14M-4.16M-0.30M-0.35M-0.23M-0.23M-0.22M-0.22M-0.20M-0.14M-0.08M-0.11M-0.14M-0.08M-0.08M-0.16M
Depreciation and DepletionDep. & Depletion
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Share-based CompensationStock Comp.
0.04M0.40M0.04M0.07M0.04M0.08M0.04M0.04M0.04M0.04M0.04M0.04M0.03M
Deferred Taxes
0.03M-0.02M-807.000.01M-0.01M0.01M
Asset Writedowns and ImpairmentWritedown
Cash from OperationsCash from Ops.
0.38M-0.03M-0.03M-0.06M0.00M0.01M-0.03M188.00-0.00M-0.00M-0.00M-0.00M-0.01M-0.00M-787.00-0.00M-839.00124.000.01M0.01M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.83M1.66M-1.76M-1.61M-0.15M-0.10M-0.07M-0.06M
Change in InventoryChange Inventory
-0.29M
Change in Account PayablesChange Payables
1.37M0.05M0.09M0.07M0.27M0.07M1.000.03M0.03M0.07M0.08M0.04M
Change in Accured ExpensesChange Accured Exp.
-1.25M0.03M0.12M0.11M0.02M0.06M-0.03M0.08M0.05M0.04M0.08M-0.00M0.04M0.06M0.06M
Change in TaxesChange Taxes
0.21M0.08M-0.04M-0.04M0.01M0.08M0.02M0.01M0.01M0.01M0.00M-0.00M
Other Working Capital ChangesOther WC Changes
-0.01M-334.00-0.04M-0.04M-0.05M-0.07M-0.04M-0.04M-0.04M-0.04M0.05M-0.14M295.000.01M773.00745.00-0.01M-150.00
Investing Activities
Capital ExpendituresCapex
Cash from Investing ActivitiesCash from Investing
0.02M-0.15M
Financing Activities
Other financing activitiesOther financing
Cash from Financing ActivitiesCash from Financing
0.00M0.00M0.00M0.01M0.00M515.000.00M0.00M
Debt Issuance and Repayment
Current Debt
15.00
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
Additional items
Change in Cash
-0.74M-0.12M-0.03M-0.06M0.00M0.01M-0.03M0.00M-0.00M-0.00M955.000.00M-0.00M-0.00M-272.00799.000.00M124.000.01M0.01M
Beginning Cash Balance
Free Cash FlowFCF
0.38M-0.03M-0.03M-0.06M0.00M0.01M-0.03M188.00-0.00M-0.00M-0.00M-0.00M-0.01M-0.00M-787.00-0.00M-839.00124.000.01M0.01M
Net Cash FlowNCF
0.40M-0.17M-0.03M-0.06M0.00M0.01M-0.03M0.00M-0.00M-0.00M955.000.00M-0.00M-0.00M-272.00799.000.00M124.000.01M0.01M

Vitaspring Biomedical Cash Flow Statement API

Pull Vitaspring Biomedical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VSBC&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY